At Acres Biosciences, we offer specialized fibroblast-focused in vitro, in vivo and ex vivo services to accelerate discovery and development of anti-fibrotic and anti-inflammatory therapies. Our team combines deep biological expertise with customizable study designs across key disease indications—including IPF, IBD, liver fibrosis, and rheumatoid arthritis.
We provide fibroblast-focused in vitro, in vivo, and ex vivo services to support preclinical research in fibrosis and inflammatory diseases. Our platform combines primary cell-based assays and disease-relevant models to generate actionable data across key tissue systems.